Financial results - CITOPAP S.R.L.

Financial Summary - Citopap S.r.l.
Unique identification code: 18152923
Registration number: J13/3701/2005
Nace: 8622
Sales - Ron
117.768
Net Profit - Ron
3.840
Employee
6
The most important financial indicators for the company Citopap S.r.l. - Unique Identification Number 18152923: sales in 2023 was 117.768 euro, registering a net profit of 3.840 euro and having an average number of 6 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Citopap S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 48.432 61.331 77.188 76.601 44.202 46.078 31.762 58.453 83.554 117.768
Total Income - EUR 48.512 61.355 77.214 76.680 44.223 64.699 32.003 58.454 83.556 117.769
Total Expenses - EUR 60.012 54.810 69.509 74.095 54.785 76.664 58.561 81.776 79.612 112.752
Gross Profit/Loss - EUR -11.500 6.545 7.705 2.585 -10.562 -11.964 -26.558 -23.322 3.944 5.017
Net Profit/Loss - EUR -12.956 4.705 6.933 1.272 -11.002 -12.611 -26.869 -23.907 3.109 3.840
Employees 4 3 3 3 3 2 3 6 6 6
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 41.4%, from 83.554 euro in the year 2022, to 117.768 euro in 2023. The Net Profit increased by 741 euro, from 3.109 euro in 2022, to 3.840 in the last year.

Check the financial reports for the company - Citopap S.r.l.

Rating financiar

Financial Rating -
Citopap S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Citopap S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Citopap S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Citopap S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Citopap S.r.l. - CUI 18152923

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 19.365 22.136 28.935 22.484 16.218 10.475 8.295 6.174 23.357 53.413
Current Assets 36.675 47.079 54.726 53.565 61.155 81.525 41.827 23.474 29.053 32.553
Inventories 0 0 0 0 8.662 7.202 12.122 0 0 2.107
Receivables 29.220 30.112 30.325 31.593 31.808 54.182 11.773 14.291 21.225 23.981
Cash 7.456 16.967 24.401 21.972 20.685 20.142 17.932 9.183 7.828 6.466
Shareholders Funds 22.151 27.041 6.977 8.131 -3.019 -15.572 -42.146 -65.118 -62.212 -58.183
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 33.889 42.426 76.689 67.917 80.393 107.573 92.269 94.767 120.110 144.149
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 32.553 euro in 2023 which includes Inventories of 2.107 euro, Receivables of 23.981 euro and cash availability of 6.466 euro.
The company's Equity was valued at -58.183 euro, while total Liabilities amounted to 144.149 euro. Equity increased by 3.840 euro, from -62.212 euro in 2022, to -58.183 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Citopap S.r.l.

Comments - Citopap S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.